High Flow Oxygen in Patients Undergoing Suspension Laryngoscopy Under General Anesthesia (OxALa)
Apneic Oxygenation Using Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) in Adult Patients Undergoing Suspension Laryngoscopy Under General Anesthesia: a Multicenter Study
Sponsor: CMC Ambroise Paré
Terminated
Risk-benefit analysis
Listed as NCT03472118, this NA trial focuses on Anesthesia and Apnea and remains terminated or withdrawn. Sponsored by CMC Ambroise Paré, it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jul 2019 — Jan 2021 [monthly]
Terminated NA
-
Apr 2019 — Jul 2019 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 5 earlier versions
-
Oct 2018 — Apr 2019 [monthly]
Recruiting NA
-
Aug 2018 — Oct 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CMC Ambroise Paré
For direct contact, visit the study record on ClinicalTrials.gov .